This class supplements the mini-course, “Pills, Politics, and the Public Good: Ethical Crossroads in the Pharmaceutical Industry.” It is intended for students who wish to delve more deeply into issues presented in that course through small group discussion and collaborative investigation. . This is a class for people with initiative, independence, and a taste for adventure.
Students in the research seminar will also serve as discussion leaders for some sessions in the mini-course (RCIDIV 350), and work with the instructor on aspects of course planning. One or two core research projects will be worked up collaboratively and developed throughout the term. Simply as examples of potential topics:
- Various issues associated with the use of unprescribed “performance-enhancing” drugs (e.g., Adderall) on campus.
- A range of issues (e.g., contracts, clinical trials, research design, publication, etc.) that emerge within collaborations between pharmaceutical companies and large research universities (like U-M).
There are many other possible topics. Sessions will include whole class meetings, “field trips,” and the chance to meet with guest experts in a small group setting.
The primary research model is responsible investigative journalism, including the use of fieldwork, informants, interviewing, and creative internet searching. A love of “following leads” is essential.
There will also be individual meetings on research projects.
***PREREQUISITES: Concurrent or prior enrollment in RCIDIV 350, “Pills, Politics and the Public Good: Ethical Crossroads in the Pharmaceutical Industry," and permission of the instructor (email:email@example.com).
mini-course. During the first half of the term, the class will meet on Tuesdays, 5-7 pm. After Spring Break, we will continue to meet from 6-7, and then join the large mini-course that meets from 7-9. During this period, there will also be individual meetings on research projects.